ID
INVG
Investing
The funds will be used to expand entry into new markets, including Medicaid.
The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives.
The company will use the funds to expand access to its hormonal healthcare platform across the U.S.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.
KOSDAQ-listed company JLK's CEO Dong-Min Kim explains how they intend to capture the world's largest medical imaging market this year.
Mudit Garg, CEO of Qventus, sat down with MobiHealthNews in San Francisco to discuss the company's $105 million funding round announced today.
Josh Sackman, president and cofounder of AppliedVR, provides MobiHealthNews with an overview of the medical XR space. He focuses on the challenges and progress in the sector.